Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
October 17, 2020 02:00 pm

Rapid research in a deadly epidemic pays off


CDC / Frederick A. Murphy EBOLA

Image: CDC

This week’s US Food and Drug Administration approval of an Ebola drug is a big milestone in drug development — one that’s closely tied to our current efforts to fight COVID-19.


Before COVID-19 started sweeping across the world, Ebola was one of the most high-profile viral diseases on the planet. “Everyone was ready to speed up and contribute and do things with Ebola that they don’t routinely do because Ebola is such a dire situation,” virologist Daniel Bausch told The Verge’s Justine Calma last August. “There are a lot of bad diseases in the world, but there’s not many that provoke the same sort of response and kind of an all-hands-on-deck approach to things.”



More than a year later, and the Ebola experiments have finally paid off in...



Continue reading…




Original Link: https://www.theverge.com/2020/10/17/21520540/antivirus-ebola-covid-treatment-development-outbreak

Share this article:    Share on Facebook
View Full Article

The Verge

The Verge is an ambitious multimedia effort founded in 2011

More About this Source Visit The Verge